Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse
Between the Biotech Waves
00:00
The Impact of the Inflation Reduction Act on the Private Market
The tech-enabled biotech opportunity or positioning that exists. There's still a very high bar and uncertainty as to how to really assess differential performance between some of those technology platforms. And then there's the interest level that we had in one particular process that was very robust, but another market environment may have been overlooked.
Play episode from 38:18
Transcript
